A new therapeutic approach to treat diabetic retinopathy. (Innolink: 101.499 IP-LS)

• Unité de recherche: INNOSUISSE
• Numéro de projet: 101.499 IP-LS
• Titre du projet anglais: A new therapeutic approach to treat diabetic retinopathy. (Innolink: 101.499 IP-LS)

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

Diabetic retinopathy is the most common diabetes-specific complication that can lead to blindness due to microvascular damage and breakdown of the blood-retinal barrier. Based on our unique mode of action drug that increases cGMP levels, we aim to restore healthy ocular microcirculation.